Myeloma Incidence and Mortality by Year, Black Individuals, New York State, 1976-2020

Source: New York State Cancer Registry

Year of Diagnosis/Death Incidence Mortality
Males and Females Males Females Males and Females Males Females
Cases Rate per 100,000 Population 95% CI Cases Rate per 100,000 Males 95% CI Cases Rate per 100,000 Females 95% CI Deaths Rate per 100,000 Population 95% CI Deaths Rate per 100,000 Males 95% CI Deaths Rate per 100,000 Females 95% CI
1976 122 9.0 7.3-10.9 58 10.9 8.0-14.5 64 7.8 5.9-10.1 72 5.4 4.1-7.0 30 4.9 3.2-7.1 42 5.6 3.9-7.7
1977 122 9.1 7.4-11.0 54 10.4 7.3-14.1 68 8.4 6.4-10.7 81 6.4 4.9-8.1 40 8.9 6.0-12.5 41 5.1 3.5-7.0
1978 121 8.7 7.1-10.5 64 13.1 9.6-17.2 57 6.3 4.7-8.3 61 4.4 3.3-5.7 34 7.3 4.7-10.6 27 2.9 1.9-4.2
1979 141 9.3 7.7-11.0 63 10.3 7.7-13.6 78 8.6 6.7-10.8 72 5.0 3.8-6.3 31 5.4 3.4-7.9 41 4.7 3.3-6.5
1980 153 10.1 8.4-12.0 61 10.7 7.9-14.1 92 9.8 7.8-12.1 99 6.6 5.3-8.2 43 7.5 5.2-10.4 56 6.1 4.5-8.0
1981 152 9.9 8.3-11.7 64 10.7 8.0-13.9 88 9.4 7.5-11.7 82 5.6 4.3-7.0 34 6.5 4.3-9.3 48 5.1 3.7-6.8
1982 166 10.5 8.9-12.3 78 12.2 9.4-15.5 88 9.3 7.3-11.5 113 7.0 5.7-8.5 58 9.1 6.7-12.1 55 5.7 4.2-7.5
1983 146 8.7 7.3-10.3 65 9.5 7.1-12.3 81 8.1 6.4-10.1 102 6.5 5.2-8.0 41 7.1 4.9-9.8 61 6.2 4.7-8.1
1984 181 10.8 9.2-12.6 81 12.6 9.7-16.0 100 9.8 7.9-12.0 116 7.1 5.8-8.6 43 6.8 4.8-9.4 73 7.3 5.6-9.2
1985 172 9.7 8.2-11.3 75 11.6 8.8-14.9 97 8.7 7.0-10.7 109 6.2 5.0-7.5 54 8.2 5.9-10.9 55 5.1 3.8-6.7
1986 186 10.5 9.0-12.2 85 12.8 9.9-16.1 101 9.2 7.5-11.3 114 6.9 5.6-8.3 56 8.7 6.4-11.6 58 5.7 4.3-7.4
1987 164 8.8 7.5-10.3 79 11.5 8.9-14.6 85 7.3 5.8-9.1 99 5.5 4.5-6.8 53 8.2 5.9-10.9 46 4.1 3.0-5.5
1988 154 8.0 6.7-9.4 68 9.1 6.8-11.7 86 7.3 5.8-9.0 83 4.5 3.5-5.6 39 5.5 3.8-7.7 44 3.9 2.8-5.2
1989 191 10.4 8.9-12.0 86 12.3 9.6-15.6 105 9.3 7.6-11.3 90 5.1 4.1-6.3 39 6.5 4.4-9.1 51 4.5 3.3-5.9
1990 193 9.5 8.2-11.0 85 12.1 9.3-15.2 108 8.5 6.9-10.3 98 5.3 4.3-6.5 42 6.5 4.5-8.9 56 4.8 3.6-6.2
1991 204 10.3 8.9-11.9 73 10.0 7.6-12.8 131 10.5 8.8-12.5 110 5.7 4.6-6.9 45 6.7 4.7-9.1 65 5.3 4.1-6.8
1992 238 11.4 9.9-13.0 108 14.0 11.2-17.2 130 10.0 8.3-11.9 132 6.5 5.4-7.7 53 7.8 5.6-10.4 79 6.1 4.8-7.6
1993 188 8.8 7.5-10.2 81 9.8 7.6-12.4 107 8.1 6.6-9.8 114 5.5 4.5-6.7 47 6.5 4.6-8.8 67 5.1 3.9-6.5
1994 209 10.0 8.7-11.5 89 11.3 8.9-14.1 120 9.3 7.7-11.1 119 5.8 4.8-7.0 43 5.4 3.8-7.4 76 5.9 4.6-7.4
1995 215 9.8 8.5-11.3 96 12.2 9.7-15.1 119 8.7 7.2-10.4 138 6.4 5.4-7.6 59 7.5 5.6-9.9 79 5.9 4.6-7.3
1996 222 9.7 8.4-11.0 97 10.8 8.6-13.4 125 8.9 7.4-10.7 109 4.9 4.0-6.0 55 6.9 5.0-9.1 54 3.9 2.9-5.1
1997 249 10.8 9.4-12.2 111 12.3 10.0-15.0 138 9.7 8.2-11.5 134 6.0 5.0-7.1 70 8.7 6.7-11.2 64 4.6 3.5-5.8
1998 248 10.5 9.2-11.9 109 12.1 9.8-14.8 139 9.6 8.1-11.4 112 4.9 4.0-5.9 41 4.9 3.4-6.8 71 5.0 3.9-6.3
1999 253 10.5 9.2-11.9 101 10.3 8.2-12.6 152 10.3 8.8-12.1 121 5.2 4.3-6.2 48 5.3 3.8-7.1 73 5.0 3.9-6.3
2000 280 11.0 9.7-12.3 117 11.6 9.4-14.1 163 10.5 9.0-12.3 116 5.0 4.1-6.0 42 4.8 3.4-6.6 74 5.0 3.9-6.3
2001 300 11.7 10.4-13.1 125 12.4 10.1-14.9 175 11.2 9.6-13.0 136 5.5 4.6-6.6 54 5.9 4.3-7.8 82 5.3 4.2-6.6
2002 290 11.1 9.9-12.5 117 12.0 9.8-14.5 173 10.8 9.2-12.5 147 5.7 4.8-6.8 59 5.6 4.2-7.4 88 5.7 4.6-7.0
2003 315 11.9 10.6-13.3 134 13.3 11.0-15.9 181 11.1 9.5-12.8 124 4.6 3.8-5.5 55 5.1 3.8-6.8 69 4.3 3.3-5.4
2004 306 11.2 9.9-12.5 129 12.1 9.9-14.5 177 10.7 9.1-12.4 136 5.3 4.5-6.3 63 6.7 5.0-8.6 73 4.6 3.6-5.8
2005 367 13.1 11.8-14.6 159 14.3 12.1-16.9 208 12.3 10.6-14.0 125 4.6 3.8-5.5 51 4.7 3.4-6.3 74 4.4 3.5-5.6
2006 359 12.6 11.3-14.0 171 15.3 13.0-17.9 188 10.9 9.4-12.6 125 4.6 3.8-5.4 60 5.6 4.2-7.3 65 3.9 3.0-4.9
2007 315 11.0 9.8-12.3 143 13.0 10.9-15.5 172 9.9 8.4-11.5 153 5.5 4.6-6.4 70 6.4 4.9-8.2 83 4.8 3.8-6.0
2008 412 13.6 12.3-15.0 190 15.9 13.6-18.4 222 12.1 10.6-13.9 118 4.2 3.5-5.0 53 4.9 3.6-6.4 65 3.7 2.9-4.8
2009 440 14.5 13.1-15.9 222 17.9 15.5-20.5 218 12.0 10.4-13.7 129 4.3 3.6-5.2 71 5.9 4.5-7.5 58 3.2 2.5-4.2
2010 440 14.2 12.9-15.6 221 18.7 16.2-21.5 219 11.6 10.1-13.3 151 5.2 4.4-6.1 69 6.3 4.8-8.0 82 4.5 3.6-5.6
2011 468 14.6 13.2-16.0 217 16.8 14.5-19.3 251 13.2 11.6-15.0 141 4.5 3.8-5.3 62 5.2 4.0-6.8 79 4.1 3.2-5.1
2012 491 14.9 13.5-16.3 229 17.7 15.3-20.2 262 13.2 11.6-14.9 144 4.4 3.7-5.2 72 5.4 4.1-6.8 72 3.7 2.9-4.7
2013 497 14.7 13.4-16.1 253 19.0 16.6-21.6 244 12.1 10.6-13.7 144 4.4 3.7-5.2 75 6.0 4.7-7.6 69 3.5 2.7-4.4
2014 514 14.8 13.6-16.2 262 18.6 16.3-21.1 252 12.4 10.9-14.1 148 4.6 3.9-5.4 68 5.6 4.3-7.1 80 4.1 3.2-5.1
2015 489 13.8 12.5-15.1 236 16.4 14.3-18.8 253 12.0 10.5-13.6 181 5.2 4.5-6.0 87 6.5 5.1-8.0 94 4.4 3.5-5.4
2016 548 14.9 13.7-16.2 263 17.9 15.7-20.3 285 13.0 11.6-14.7 170 4.9 4.2-5.7 78 5.7 4.4-7.2 92 4.5 3.6-5.5
2017 538 14.7 13.5-16.0 245 16.7 14.6-19.0 293 13.3 11.8-14.9 162 4.5 3.8-5.3 72 5.4 4.2-6.8 90 4.0 3.2-5.0
2018 543 13.9 12.8-15.2 248 15.3 13.4-17.5 295 12.9 11.5-14.5 153 4.1 3.5-4.9 73 5.3 4.1-6.7 80 3.5 2.7-4.3
2019 538 14.0 12.8-15.2 275 17.5 15.4-19.7 263 11.8 10.4-13.3 151 3.9 3.3-4.6 80 5.2 4.1-6.5 71 3.0 2.4-3.8
2020 425 11.0 9.9-12.1 195 12.5 10.7-14.4 230 10.0 8.7-11.4 126 3.2 2.7-3.8 56 3.7 2.8-4.8 70 3.0 2.4-3.9

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 20 cases or deaths per year are unstable and should be used with caution.
  • Cancer diagnoses trends in 2020 may have been affected by the coronavirus disease 19 (COVID-19) pandemic.
  • The data in this table are not identical to the data in the corresponding 2016-2020 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.